Bmrn analyst rating
WebApr 8, 2024 · In a report released on April 6, Luca Issi from RBC Capital maintained a Hold rating on BioMarin Pharmaceutical ( BMRN – Research Report ), with a price target of $100.00. The company’s shares ... WebMar 21, 2024 · According to 31 stock analysts, the average 12-month stock price forecast for BMRN stock is $126.43, which predicts an increase of 37.30%. The lowest target is …
Bmrn analyst rating
Did you know?
WebApr 10, 2024 · Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Quest Diagnostics (DGX) and Globus Medical (GMED) Mar. 17, 2024 at 5:20 … WebApr 11, 2024 · BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) CEO Jean Jacques Bienaime sold 10,000 shares of the business’s stock in a transaction dated Thursday, April 6th. The shares were sold at ...
WebApr 10, 2024 · BioMarin Pharmaceutical has received a consensus rating of Buy. The company's average rating score is 2.53, and is based on 11 buy ratings, 7 hold ratings, and 1 sell rating. Price Target Upside/Downside. …
WebApr 12, 2024 · BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last issued its earnings results on Monday, February 27th. The biotechnology company reported $0.11 earnings per share (EPS) for the quarter,... WebApr 6, 2024 · Rating: P/E Non-GAAP (FWD) 47.12 P/E GAAP (TTM) 132.80 Price/Book (TTM) 4.03 EV/Sales (TTM) 8.78 EV/EBITDA (TTM) 124.43 More On Valuation » Growth Profitability Rating: Gross Profit Margin...
WebThe 22 analysts offering 1 year price forecasts for BMRN have a max estimate of — and a min estimate of —. Analyst rating. Based on 26 analysts giving stock ratings to BMRN in the past 3 months. EPS. Annual Quarterly More
WebMar 29, 2024 · BioMarin Pharmaceutical Inc. research and ratings by Barron's. View BMRN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. script bear alphaWebAnalyst Ratings are available for US and Canadian equities. Unlike Barchart Opinions (which calculate the Buy/Sell rating using a variety of short-medium and long-term … script bean fontWebAnalyst Rating / Earnings Estimates. Current Rating See More. Moderate Buy. Based on 20 analysts offering recommendations. Earnings Estimates - Current Qtr 03/31/23 ... script bcw youtubeWebThe analyst firm set a price target for 81.00 expecting BMRN to fall to within 12 months (a possible -18.67% downside). 31 analyst firms have reported ratings in the last year. script beach beddingWebApr 9, 2024 · Analyst Ratings Changes Several brokerages have commented on BMRN. Bank of America raised their target price on shares of BioMarin Pharmaceutical to $200.00 in a report on Wednesday, January 4th. pay seaside heights water onlineWebApr 10, 2024 · BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2024 and is poised for U.S. approval in 2024. Contact. 770 Lindaro Street. San Rafael, CA, 94901. www.bmrn.com. script beauty and the beastWebApr 9, 2024 · Xponance Inc. grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Rating) by 81.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission.The institutional investor owned 6,503 shares of the biotechnology company's stock after purchasing an additional … script beat board